{
    "eid": "2-s2.0-85150042099",
    "title": "The immunogenicity of an extended dosing interval of BNT162b2 against SARS-CoV-2 Omicron variant among healthy school-aged children, a randomized controlled trial",
    "cover-date": "2023-05-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Microbiology (medical)",
            "@code": "2726",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Infectious Diseases",
            "@code": "2725",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Antibody",
        "BNT162b2",
        "Children",
        "COVID-19 vaccine",
        "Dosing interval",
        "SARS-CoV-2"
    ],
    "authors": [
        "Napaporn Chantasrisawad",
        "Chonnamet Techasaensiri",
        "Pope Kosalaraksa",
        "Wanatpreeya Phongsamart",
        "Auchara Tangsathapornpong",
        "Peera Jaru-Ampornpan",
        "Jiratchaya Sophonphan",
        "Piyarat Suntarattiwong",
        "Thanyawee Puthanakit"
    ],
    "citedby-count": 1,
    "ref-count": 30,
    "ref-list": [
        "Hospitalizations of children aged 5\u201311 years with laboratory-confirmed COVID-19 - COVID-NET, 14 states, March 2020\u2013February 2022",
        "Post-COVID-19 symptoms and conditions among children and adolescents - United States, March 1, 2020\u2013January 31, 2022",
        "The Advisory Committee on Immunization Practices' interim recommendation for use of Pfizer-BioNTech COVID-19 vaccine in children aged 5\u201311 years - United States, November 2021",
        "Evaluation of the BNT162b2 Covid-19 vaccine in children 5 to 11 years of age",
        "Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA vaccination in preventing COVID-19-associated emergency department and urgent care encounters and hospitalizations among nonimmunocompromised children and adolescents aged 5\u201317 years - VISION network, 10 states, April 2021\u2013January 2022",
        "Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA vaccination against multisystem inflammatory syndrome in children among persons aged 12\u201318 years - United States, July\u2013December 2021",
        "Covid-19 vaccine protection among children and adolescents in Qatar",
        "Effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection and severe COVID-19 in children aged 5\u201311 years in Italy: a retrospective analysis of January\u2013April, 2022",
        "Effectiveness of BNT162b2 vaccine against omicron in children 5 to 11 years of age",
        "Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine",
        "Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England",
        "Two-dose severe acute respiratory syndrome coronavirus 2 vaccine effectiveness with mixed schedules and extended dosing intervals: test-negative design studies from British Columbia and Quebec",
        "Epidemiology of myocarditis and pericarditis following mRNA vaccination by vaccine product, schedule, and interdose interval among adolescents and adults in Ontario, Canada",
        "A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein-protein interaction",
        "Suggested guidelines for convalescent plasma therapy for the treatment of COVID-19",
        "Pseudotype neutralization assays: from laboratory bench to data analysis",
        "Chimeric virus-like particle-based COVID-19 vaccine confers strong protection against SARS-CoV-2 viremia in K18-hACE2 mice",
        "A single-cycle influenza A virus-based SARS-CoV-2 vaccine elicits potent immune responses in a mouse model",
        "A serological assay to detect SARS-CoV-2 seroconversion in humans",
        "Research Electronic Data Capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support",
        "The REDCap consortium: building an international community of software platform partners",
        "mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern",
        "SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses",
        "Increased B cell selection stringency in germinal centers can explain improved COVID-19 vaccine efficacies with low dose prime or delayed boost",
        "Immunogenicity of a fractional dose of mRNA BNT162b2 COVID-19 vaccine for primary series and booster vaccination among healthy adolescents",
        "Analysis of COVID-19 vaccine type and adverse effects following vaccination",
        "COVID-19 vaccine safety in children aged 5\u201311 years - United States, November 3\u2013December 19, 2021",
        "Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60199575",
            "affilname": "Siriraj Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199575",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Khon Kaen",
            "@id": "60026046",
            "affilname": "Faculty of Medicine, Khon Kaen University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026046",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60015887",
            "affilname": "Faculty of Medicine Ramathibodi Hospital, Mahidol University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015887",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Pathum Thani",
            "@id": "60013939",
            "affilname": "Faculty of Medicine, Thammasat University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60013939",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Pathum Thani",
            "@id": "60011947",
            "affilname": "Thailand National Center for Genetic Engineering and Biotechnology",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60011947",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60010778",
            "affilname": "Queen Sirikit National Institute of Child Health",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60010778",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Center of Excellence in Pediatric Infectious Diseases and Vaccines",
        "Department of Diseases Control",
        "Monoclonal Antibody Production and Application Research Team",
        "National Vaccine Institute, Thailand",
        "Queen Sirikit National Institute of Child Health",
        "Siriraj Hospital Mahidol University",
        "Thanapon Nimsomboon",
        "Chulalongkorn University",
        "Khon Kaen University",
        "Mahidol University",
        "Ministry of Public Health, Thailand",
        "Thammasat University",
        "IRB",
        "Siriraj Hospital"
    ]
}